Recent Advances in Melanoma Care

Dr. Ferris is a professor of dermatology at the University of Pittsburgh. She directs the pigmented lesions clinic and is the director of clinical research for the department of dermatology and is a member of the UPMC Hillman Cancer Center Melanoma Program. Her melanoma interests include early detection of skin cancer through screening and the use of technology. 

Michael Postow is a medical oncologist and the Chief of the Melanoma Service at Memorial Sloan Kettering Cancer Center. He led the first randomized trial of combination immune checkpoint inhibition (nivolumab + ipilimumab), resulting in its FDA approval. He has also written and presented on topics related to immunotherapy outcomes and side effects and studied new ways to combine immunotherapy with local treatments (i.e. radiation).  His completed and ongoing work continue to impact cancer patients and advance immunotherapy for melanoma and other diseases. He enjoys skiing, outdoor activities, and trying to keep up with his two toddlers and triathlete wife.